BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1388 related articles for article (PubMed ID: 25037622)

  • 1. Use of balloon expandable transcatheter valves for valve-in-valve implantation in patients with degenerative stentless aortic bioprostheses: Technical considerations and results.
    Bapat V; Davies W; Attia R; Hancock J; Bolter K; Young C; Redwood S; Thomas M
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):917-22; discussion 922-4. PubMed ID: 25037622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of transcatheter heart valves for a valve-in-valve implantation in patients with degenerated aortic bioprosthesis: technical considerations and results.
    Bapat V; Attia R; Redwood S; Hancock J; Wilson K; Young C; Thomas M
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1372-9; discussion 1379-80. PubMed ID: 23140962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
    Gonska B; Seeger J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):636-643. PubMed ID: 27142354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter aortic valve implantation for treatment of patients with degenerated aortic bioprostheses--valve-in-valve technique.
    Gotzmann M; Mügge A; Bojara W
    Catheter Cardiovasc Interv; 2010 Dec; 76(7):1000-6. PubMed ID: 20824744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
    Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter aortic valve implantation for high risk patients with severe aortic stenosis using the Edwards Sapien balloon-expandable bioprosthesis: a single centre study with immediate and medium-term outcomes.
    Osten MD; Feindel C; Greutmann M; Chamberlain K; Meineri M; Rubin B; Mezody M; Ivanov J; Butany J; Horlick EM
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):475-85. PubMed ID: 19937781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter aortic valve-in-valve treatment of degenerative stentless supra-annular Freedom Solo valves: A single centre experience.
    Cockburn J; Dooley M; Parker J; Hill A; Hutchinson N; de Belder A; Trivedi U; Hildick-Smith D
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):438-444. PubMed ID: 27315455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical sutureless and transcatheter aortic valves: hemodynamic performance and clinical outcomes in propensity score-matched high-risk populations with severe aortic stenosis.
    Kamperidis V; van Rosendael PJ; de Weger A; Katsanos S; Regeer M; van der Kley F; Mertens B; Sianos G; Ajmone Marsan N; Bax JJ; Delgado V
    JACC Cardiovasc Interv; 2015 Apr; 8(5):670-7. PubMed ID: 25946438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early experience of implantation of the new CoreValve(®) Evolut(™) in degenerated bioprosthetic aortic valves.
    Fairley SL; Jeganathan R; Manoharan G; Spence MS
    Catheter Cardiovasc Interv; 2014 Feb; 83(3):485-92. PubMed ID: 23857751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of patient-prosthesis mismatch after transcatheter aortic valve-in-valve implantation in degenerated bioprostheses.
    Seiffert M; Conradi L; Baldus S; Knap M; Schirmer J; Franzen O; Koschyk D; Meinertz T; Reichenspurner H; Treede H
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):617-24. PubMed ID: 22169448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which available transapical transcatheter valve fits into degenerated aortic bioprostheses?
    Ferrari E; Marcucci C; Sulzer C; von Segesser LK
    Interact Cardiovasc Thorac Surg; 2010 Jul; 11(1):83-5. PubMed ID: 20395247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.
    Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age.
    Christ T; Grubitzsch H; Claus B; Konertz W
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):264-9. PubMed ID: 23158257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcarotid aortic valve-in-valve implantation for degenerated stentless aortic root conduits with severe regurgitation: a case series.
    Huber C; Praz F; O'Sullivan CJ; Langhammer B; Gloekler S; Stortecky S; von Allmen RS; Meier B; Carrel T; Englberger L; Windecker S; Wenaweser P
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):694-700. PubMed ID: 25776924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter aortic valve implantation for treatment of failing homograft with preexisting mechanical mitral prosthesis.
    Attia R; Bapat V
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):324-7. PubMed ID: 22120953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balloon-expandable prostheses for transcatheter aortic valve replacement.
    Ribeiro HB; Urena M; Allende R; Amat-Santos IJ; Rodés-Cabau J
    Prog Cardiovasc Dis; 2014; 56(6):583-95. PubMed ID: 24838134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-in-human valve-in-valve implantation of a 20 mm balloon expandable transcatheter heart valve.
    Binder RK; Wood D; Webb JG; Cheung A
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E929-31. PubMed ID: 22821872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.
    Schymik G; Lefèvre T; Bartorelli AL; Rubino P; Treede H; Walther T; Baumgartner H; Windecker S; Wendler O; Urban P; Mandinov L; Thomas M; Vahanian A
    JACC Cardiovasc Interv; 2015 Apr; 8(5):657-69. PubMed ID: 25946437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes Following Transcatheter Aortic Valve Replacement for Degenerative Stentless Versus Stented Bioprostheses.
    Duncan A; Moat N; Simonato M; de Weger A; Kempfert J; Eggebrecht H; Walton A; Hellig F; Kornowski R; Spargias K; Mendiz O; Makkar R; Guerrero M; Rihal C; George I; Don C; Iadanza A; Bapat V; Welsh R; Wijeysundera HC; Wood D; Sathananthan J; Danenberg H; Maisano F; Garcia S; Gafoor S; Nombela-Franco L; Cobiella J; Dvir D
    JACC Cardiovasc Interv; 2019 Jul; 12(13):1256-1263. PubMed ID: 31202944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prosthesis-Specific Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Impact of Calcification and Sizing on Balloon-Expandable versus Self-Expandable Transcatheter Heart Valves.
    Stähli BE; Nguyen-Kim TD; Gebhard C; Erhart L; Frauenfelder T; Tanner FC; Falk V; Landmesser U; Nietlispach F; Lüscher TF; Maier W; Binder RK
    J Heart Valve Dis; 2015 Jan; 24(1):10-21. PubMed ID: 26182615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.